Tilseq Trademark Details
Word Mark | Tilseq |
---|---|
Status | Alive 730 — First Extension - Granted |
Current Owner
Adaptive Biotechnologies Corporation of Seattle, WA
View all trademarks for Adaptive Biotechnologies CorporationSerial Number | 86423216 |
---|---|
Status Date | Monday, March 7, 2016 |
Filing Date | Monday, March 7, 2016 |
Attorney | Hoang-chi Truong |
Correspondent
HOANG-CHI TRUONG
PATENT LAW WORKS LLP
201 S. MAIN STREET, SUITE 250
SALT LAKE CITY, UT 84111
PATENT LAW WORKS LLP
201 S. MAIN STREET, SUITE 250
SALT LAKE CITY, UT 84111
Case File Statements
Goods & Services | Scientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors |
---|---|
Goods & Services | Providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses to immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes |
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, October 21, 2014 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Friday, May 29, 2015 |
Primary Code | 044 |
Trademark Timeline
-
Oct 14 2014Trademark application filed with USPTO
-
Oct 17 2014New Application Entered In Tram
-
Oct 21 2014New Application Office Supplied Data Entered In Tram
-
Dec 03 2014Assigned To Examiner
-
Dec 04 2014Notification of Non-Final Action E-Mailed
-
Dec 04 2014Non-Final Action E-Mailed
-
Dec 04 2014Non-Final Action Written
-
Apr 09 2015International filing request made
-
Apr 09 2015Automatically Certified
-
Apr 09 2015New Application For Ir Received
-
Apr 09 2015Ir Certified and Sent To Ib
-
May 28 2015Correspondence Received In Law Office
-
May 28 2015Teas Response To Office Action Received
-
May 29 2015Teas/email Correspondence Entered
-
Jun 02 2015Approved For Pub - Principal Register
-
Jun 17 2015Irregularity Notice Received From Ib (response Required)
-
Jun 19 2015Law Office Publication Review Completed
-
Jun 19 2015Assigned To Lie
-
Jul 08 2015Notification of Notice of Publication E-Mailed
-
Jul 28 2015Official Gazette Publication Confirmation E-Mailed
-
Jul 28 2015Published For Opposition
-
Aug 27 2015Irregularity Response Received From Applicant
-
Aug 28 2015Response To Irregularity Reviewed and Accepted
-
Aug 28 2015Irregularity Response Sent To Ib
-
Sep 22 2015Noa E-Mailed - Sou Required From Applicant
-
Nov 19 2015Application For Ir Registered By Ib
-
Feb 20 2016Correction Transaction Received From Ib
-
Mar 07 2016Extension 1 Granted
-
Mar 07 2016Extension 1 Filed
-
Mar 07 2016Teas Extension Received
-
Mar 09 2016Notice of Approval of Extension Request E-Mailed
-
Apr 06 2016Correction From the Ib Examined, No Action Is Needed
-
Sep 15 2016Teas Extension Received